Close Menu

NEW YORK – Personal Genome Diagnostics (PGDx) said on Wednesday that it has entered a strategic collaboration with the Mayo Clinic to improve clinical diagnostic oncology solutions. 

As part of the collaboration, the partners will focus on optimizing technology and conducting clinical utility studies for liquid biopsy and tissue-based genomic applications, combining Mayo Clinic's clinical knowledge and expertise in oncology and PGDx's experience with genomic technology. 

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.